Current guidelines recommend endoscopic management (EM) for patients with low‐risk
upper urinary tract urothelial carcinoma, as well as those with an imperative indication …

Primary upper tract carcinoma in situ (UTcis) is a rare disease whose diagnosis and natural
history are poorly understood. Radical nephroureterectomy is the standard of care but in …

Background Nephrostomy tubes are commonly placed for urinary obstruction, urinary
diversion, or future endourologic procedures. While the technical success of nephrostomy …

Urothelial carcinoma of the upper urinary tract is uncommon and presents unique
challenges for diagnosis and management. Nephroureterectomy has been the preferred …

Background Intracavitary UGN-101 is approved for the treatment of low-grade noninvasive
upper tract urothelial carcinoma (UTUC). Post-commercialization studies underscore the …

Upper urinary tract urothelial carcinomas (UTUCs) are often identified and first treated
endoscopically. After proper risk stratification, adjuvant treatment may be recommended …

Introduction The world population is ageing and surgical procedures for older patients are
associated with higher perioperative morbidity and mortality rates than in younger patients …

Upper tract urothelial carcinoma (UTUC) has traditionally been managed with radical
nephroureterectomy, and while this approach remains the gold standard for high-risk …

Purpose: Intracavitary chemotherapy is one of the current treatment options for kidney-
sparing treatment of upper tract urothelial carcinoma (UTUC). The purpose of this meta …

Introduction Patients with upper-tract carcinoma in situ (UT-CIS) that have failed treatment
with BCG are recommended for radical nephroureterectomy (RNU). We describe a cohort of …